[(Z)-2-((2-Methoxy-5-(3,4,5-trimethoxystyryl)phenoxy)methyl)-5-nitrothiophene

ID: ALA4642405

Chembl Id: CHEMBL4642405

PubChem CID: 11408474

Max Phase: Preclinical

Molecular Formula: C23H23NO7S

Molecular Weight: 457.50

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OCc1ccc([N+](=O)[O-])s1

Standard InChI:  InChI=1S/C23H23NO7S/c1-27-18-9-7-15(11-19(18)31-14-17-8-10-22(32-17)24(25)26)5-6-16-12-20(28-2)23(30-4)21(13-16)29-3/h5-13H,14H2,1-4H3/b6-5-

Standard InChI Key:  PPNUFQSDBKPTKU-WAYWQWQTSA-N

Associated Targets(Human)

TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Por NADPH--cytochrome P450 reductase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 457.50Molecular Weight (Monoisotopic): 457.1195AlogP: 5.44#Rotatable Bonds: 10
Polar Surface Area: 89.29Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.27CX LogD: 5.27
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.23Np Likeness Score: -0.56

References

1. Winn BA, Devkota L, Kuch B, MacDonough MT, Strecker TE, Wang Y, Shi Z, Gerberich JL, Mondal D, Ramirez AJ, Hamel E, Chaplin DJ, Davis P, Mason RP, Trawick ML, Pinney KG..  (2020)  Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.,  83  (4): [PMID:32196334] [10.1021/acs.jnatprod.9b00773]

Source